{"product_id":"nubeqal-darolutamida-tabletas-300mg-con-120","title":"Nubeqal (Darolutamide) 300mg Tablets with 120","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003ePrescription medications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eOncology\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eNubeqal\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eDarolutamide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e300 mg tablets, bottle with 120 tablets\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eWecare Pharma\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eNubeqal (Darolutamide) is indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer. This medication acts as an androgen receptor inhibitor, interfering with androgen signaling that can lead to tumor growth and progression. The efficacy of Darolutamide has been evaluated in clinical studies, where its ability to delay disease progression compared to standard treatment has been demonstrated. Its use is recommended under the supervision of a specialized oncology physician.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Nubeqal tablet contains 300 mg of Darolutamide as the active ingredient. It also contains excipients that facilitate the formulation and stability of the medication.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eNubeqal is contraindicated in patients with known hypersensitivity to Darolutamide or any of the excipients in the formulation. It is also contraindicated in women and children, as safety and efficacy have not been established in these populations. Its use in combination with certain other treatments should be evaluated by a physician due to potential interactions.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eBefore starting treatment with Nubeqal, a complete medical evaluation is important. The patient's pre-existing medical conditions, as well as other treatments they are receiving, should be considered. Regular follow-up during treatment is recommended to evaluate the therapeutic response and the appearance of adverse effects. In case of unusual symptoms, a doctor should be consulted immediately.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore Nubeqal in its original packaging, at room temperature, protected from light and humidity. Keep out of reach of children. Do not use after the expiration date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Wecare Pharma","offers":[{"title":"Default Title","offer_id":46299893694689,"sku":"10963","price":105369.23,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/WeCare-Pharma-Producto_02e490bb-9969-4071-a1ac-4724d5f45a82.jpg?v=1744716987","url":"https:\/\/wecarepharma.mx\/en\/products\/nubeqal-darolutamida-tabletas-300mg-con-120","provider":"WeCare Pharma","version":"1.0","type":"link"}